There are several promising ongoing trials using CAR T cells to target antigens expressed in PCa including PSCA (NCT02744287), PSMA (NCT01140373), EpCAM (NCT03013712), and NY-ESO-1 (NCT03159585). Here, EPCAM is linked to posterior cortical atrophy.